CERV-MRD-Surveillance v2.5 — code, protocol, and outputs for "Clinical and Economic Thresholds for HPV Circulating Tumor DNA Surveillance in Cervical Cancer"
Authors/Creators
- 1. Longhua Hospital Shanghai University of Traditional Chinese Medicine
- 2. Shanghai University
Description
Reproducibility archive for a patient-level microsimulation that solves for the causal increase in curative-intent salvage eligibility (δ) that HPV circulating tumor DNA surveillance after chemoradiotherapy for cervical cancer must produce to improve quality-adjusted survival and to be cost-effective.
Contents: protocol with dated amendments, parameter ledger, simulation engine and verification tests (Python/NumPy, fixed seeds), and all outputs. Manuscript files are not included.
Version 2.5.0 re-expresses the molecular-lead, detection-delay, and value-of-information analyses under the primary (local and regional) estimand, corrects the clinical value-of-information summary and the population-scale conversion factor, and adds labelled post hoc scenarios; every change is documented in protocol/amendments/v2.5_jamaonc_retarget.md, with reproduction checks against the frozen v2.2 outputs.
Reproduce: see ARCHIVE_SCOPE.md. Code MIT; documentation and text CC-BY-4.0.